131 related articles for article (PubMed ID: 31059049)
1. LINC01638 silencing inhibits cancer cell proliferation in colorectal adenocarcinoma through interaction with RUNX2.
Zhuo W; Hu D; Chen X; Zhang T
Mol Med Rep; 2019 Jun; 19(6):5275-5280. PubMed ID: 31059049
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of LINC01638 lncRNA inhibits migration and invasion of pancreatic ductal adenocarcinoma cells by reducing TGF‑β signaling.
Lu H; Ye J; Zhang L; Li M; Lu S; Yang D; Hu W
Mol Med Rep; 2019 Nov; 20(5):4533-4539. PubMed ID: 31702018
[TBL] [Abstract][Full Text] [Related]
3. LINC01638 lncRNA promotes the proliferation, migration and invasion of prostate carcinoma cells by interacting with Notch1.
Wu Z; Huang W; Chen Y; Chen B; Liu R; Bai P; Xing J
Cancer Biomark; 2019; 25(2):161-168. PubMed ID: 31104008
[TBL] [Abstract][Full Text] [Related]
4. lncRNA HAND2-AS1 overexpression inhibits cancer cell proliferation in hepatocellular carcinoma by downregulating RUNX2 expression.
Jing GY; Zheng XZ; Ji XX
J Clin Lab Anal; 2021 Apr; 35(4):e23717. PubMed ID: 33566427
[TBL] [Abstract][Full Text] [Related]
5. Down regulation of lncRNA MEG3 promotes colorectal adenocarcinoma cell proliferation and inhibits the apoptosis by up-regulating TGF-β1 and its downstream sphingosine kinase 1.
Dong X; Wang J; Li T; Xu YP; Li SY
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8265-8272. PubMed ID: 30556866
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of MANCR inhibits cancer cell proliferation in mantle cell lymphoma possibly by interacting with RUNX2.
Wen S; Zeng M; Li Y; Hu X; Li S; Liang X; Zhu L; Yang S
Acta Biochim Biophys Sin (Shanghai); 2019 Nov; 51(11):1142-1147. PubMed ID: 31650163
[TBL] [Abstract][Full Text] [Related]
7. Prognostic and predictive value of long non-coding RNA GAS5 and mircoRNA-221 in colorectal cancer and their effects on colorectal cancer cell proliferation, migration and invasion.
Liu L; Meng T; Yang XH; Sayim P; Lei C; Jin B; Ge L; Wang HJ
Cancer Biomark; 2018; 22(2):283-299. PubMed ID: 29630521
[TBL] [Abstract][Full Text] [Related]
8. Upregulated Long Noncoding RNA LINC01234 Predicts Unfavorable Prognosis for Colorectal Cancer and Negatively Correlates With KLF6 Expression.
Jiang X; Zhu Q; Wu P; Zhou F; Chen J
Ann Lab Med; 2020 Mar; 40(2):155-163. PubMed ID: 31650732
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA FOXP4-AS1 is an unfavourable prognostic factor and regulates proliferation and apoptosis in colorectal cancer.
Li J; Lian Y; Yan C; Cai Z; Ding J; Ma Z; Peng P; Wang K
Cell Prolif; 2017 Feb; 50(1):. PubMed ID: 27790757
[TBL] [Abstract][Full Text] [Related]
10. LINC01638 lncRNA mediates the postoperative distant recurrence of bladder cancer by upregulating ROCK2.
Yuan S; Luan X; Han G; Guo K; Wang S; Zhang X
Oncol Lett; 2019 Nov; 18(5):5392-5398. PubMed ID: 31620199
[TBL] [Abstract][Full Text] [Related]
11. LncRNA AWPPH and miRNA-21 regulates cancer cell proliferation and chemosensitivity in triple-negative breast cancer by interacting with each other.
Liu AN; Qu HJ; Gong WJ; Xiang JY; Yang MM; Zhang W
J Cell Biochem; 2019 Sep; 120(9):14860-14866. PubMed ID: 31033015
[TBL] [Abstract][Full Text] [Related]
12. LINC01638 lncRNA promotes cancer cell proliferation in hepatocellular carcinoma by increasing cancer cell glucose uptake.
Chen X; Wang L; Wang H
Oncol Lett; 2019 Oct; 18(4):3811-3816. PubMed ID: 31516592
[TBL] [Abstract][Full Text] [Related]
13. The lncRNA MALAT1 is a novel biomarker for gastric cancer metastasis.
Xia H; Chen Q; Chen Y; Ge X; Leng W; Tang Q; Ren M; Chen L; Yuan D; Zhang Y; Liu M; Gong Q; Bi F
Oncotarget; 2016 Aug; 7(35):56209-56218. PubMed ID: 27486823
[TBL] [Abstract][Full Text] [Related]
14. LncRNA GAS8-AS inhibits colorectal cancer (CRC) cell proliferation by downregulating lncRNA AFAP1-AS1.
Zhao Y; Chu Y; Sun J; Song R; Li Y; Xu F
Gene; 2019 Aug; 710():140-144. PubMed ID: 31132513
[TBL] [Abstract][Full Text] [Related]
15. Linc01638 Promotes Tumorigenesis in HER2+ Breast Cancer.
Liu P; Tang H; Wu J; Qiu X; Kong Y; Zhang L; Xie X; Xiao X
Curr Cancer Drug Targets; 2019; 19(1):74-80. PubMed ID: 29992881
[TBL] [Abstract][Full Text] [Related]
16. SP1-regulated LINC01638 promotes proliferation and inhibits apoptosis in non-small cell lung cancer.
Guo L; Fang L; Liu Y
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8913-8920. PubMed ID: 31696478
[TBL] [Abstract][Full Text] [Related]
17. LINC01638 lncRNA activates MTDH-Twist1 signaling by preventing SPOP-mediated c-Myc degradation in triple-negative breast cancer.
Luo L; Tang H; Ling L; Li N; Jia X; Zhang Z; Wang X; Shi L; Yin J; Qiu N; Liu H; Song Y; Luo K; Li H; He Z; Zheng G; Xie X
Oncogene; 2018 Nov; 37(47):6166-6179. PubMed ID: 30002443
[TBL] [Abstract][Full Text] [Related]
18. LINC0638 lncRNA is involved in the local recurrence of melanoma following surgical resection.
Xiao W; Yin A
Oncol Lett; 2019 Jul; 18(1):101-108. PubMed ID: 31289478
[TBL] [Abstract][Full Text] [Related]
19. Effects of lncRNA DANCR on proliferation and differentiation of osteoblasts by regulating the Wnt/β-catenin pathway.
Jiang SY; Miao YX; Hirokazu T; Zhu SZ; Lu JS
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5558-5566. PubMed ID: 31298307
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of lncRNA KCNQ1OT1 suppresses the adipogenic and osteogenic differentiation of tendon stem cell via downregulating miR-138 target genes PPARγ and RUNX2.
Yu Y; Chen Y; Zhang X; Lu X; Hong J; Guo X; Zhou D
Cell Cycle; 2018; 17(19-20):2374-2385. PubMed ID: 30321077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]